Surgical implantation of steroids with antiangiogenic characteristics for treating exudative macular degeneration
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The primary aim of this review is to investigate the effects of surgically implanted steroids with anti‐angiogenic properties in delaying visual loss in exudative macular degeneration. A secondary aim of this review is to compare the clinical outcomes and side effects of different surgically implanted anti‐angiogenic steroids. A third aim is to compare the intraocular drug delivery systems used for the administration of steroids in the treatment of exudative AMD in different clinical trials.